Literature DB >> 26359330

Immunopathology of synovitis: from histology to molecular pathways.

Marleen G van de Sande1, Dominique L Baeten2.   

Abstract

Increased knowledge about pathological processes active in inflammatory joint diseases is needed to initiate personalized medicine based on targeted treatments in the future. The molecular and cellular pathways that are active during joint inflammation may differ between the various inflammatory joint diseases, between different patient subgroups within one disease, or even between different stages of the disease in a single patient. In this review, we evaluate synovial inflammation in terms of descriptive histopathology through to more functional studies on human synovial tissue inflammation in RA and SpA, in phenotypic subgroups of RA and SpA patients, and during the disease course of both diseases.
© The Author 2015. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  cytokines and inflammatory mediators; fibroblasts; histopathology; inflammation; lymphocytes; macrophages; microarrays/gene expression profiling/transcriptome; rheumatoid arthritis; spondylarthropathies; spondyloarthritis; synovium

Mesh:

Year:  2015        PMID: 26359330     DOI: 10.1093/rheumatology/kev330

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  19 in total

Review 1.  [Fifteen years of the histopathological synovitis score : Review and further developments of a diagnostic score].

Authors:  V Krenn; G Perino; W Rüther; V T Krenn; M Huber; T Hügle; A Najm; S Müller; F Boettner; F Pessler; W Waldstein; J Kriegsmann; T Häupl; S Wienert; M G Krukemeyer; S Sesselmann; R Tikhilov; L Morawietz
Journal:  Z Rheumatol       Date:  2017-08       Impact factor: 1.372

Review 2.  [Arthur Vick Prize 2017 of the German Society of Orthopaedic Rheumatology].

Authors:  L Bause; A Niemeier; V Krenn
Journal:  Z Rheumatol       Date:  2018-03       Impact factor: 1.372

Review 3.  Interleukin-9 and T helper type 9 cells in rheumatic diseases.

Authors:  F Ciccia; G Guggino; A Ferrante; P Cipriani; R Giacomelli; G Triolo
Journal:  Clin Exp Immunol       Date:  2016-08       Impact factor: 4.330

Review 4.  Cellular and molecular pathways of structural damage in rheumatoid arthritis.

Authors:  Ulrike Harre; Georg Schett
Journal:  Semin Immunopathol       Date:  2017-06-08       Impact factor: 9.623

5.  Willie Sutton Was Right: It's Time to Turn to the Synovium to Drive Rheumatoid Arthritis Therapy.

Authors:  Eric M Ruderman; Arthur M Mandelin; Harris R Perlman
Journal:  J Rheumatol       Date:  2016-12       Impact factor: 4.666

Review 6.  Histopathology of Psoriatic Arthritis Synovium-A Narrative Review.

Authors:  Catarina Tenazinha; Rita Barros; João Eurico Fonseca; Elsa Vieira-Sousa
Journal:  Front Med (Lausanne)       Date:  2022-07-01

Review 7.  [Histopathological classification principles of rheumatic joint diseases : Contribution of pathology to the diagnosis].

Authors:  V Krenn; W Waldstein; A Najm; G Perino; R Gaulke
Journal:  Orthopade       Date:  2018-11       Impact factor: 1.087

Review 8.  Functional genomics of stromal cells in chronic inflammatory diseases.

Authors:  Kamil Slowikowski; Kevin Wei; Michael B Brenner; Soumya Raychaudhuri
Journal:  Curr Opin Rheumatol       Date:  2018-01       Impact factor: 5.006

Review 9.  Angiogenesis Dysregulation in Psoriatic Arthritis: Molecular Mechanisms.

Authors:  Francesco Paolo Cantatore; Nicola Maruotti; Addolorata Corrado; Domenico Ribatti
Journal:  Biomed Res Int       Date:  2017-07-19       Impact factor: 3.411

Review 10.  Rheumatoid Arthritis and miRNAs: A Critical Review through a Functional View.

Authors:  Maria Cristina Moran-Moguel; Stefania Petarra-Del Rio; Evangelina E Mayorquin-Galvan; Maria G Zavala-Cerna
Journal:  J Immunol Res       Date:  2018-03-29       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.